Type 1 diabetes

Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data

BMJ Open Diabetes Res CarePublished Modelling study

Authors' conclusion

For the first time in Germany, we provide estimates for the incidence, prevalence, and number of people with diagnosed type 1 diabetes for the whole German population between 2010 and 2040. The relative increase of the people with type 1 diabetes ranges from 1% to 32% in 2040 compared with 2010. The projected results are mainly influenced by temporal trends in the incidence. Ignoring these trends, that is, applying a constant prevalence to population projections, probably underestimates future chronic disease numbers.

Study context

Population
Insurees of the German statutory health insurance; projection for the whole German population with diagnosed T1D, 2010–2040
Participants
65 million insurees
Outcome
Projected number of people with diagnosed T1D in Germany
Follow-up
2040
Methodological detailsclaims data, illness-death model, scenario analysis, Age- and sex-specific incidence and prevalence of T1D in 2010 estimated from claims data, then projected to 2040 with the illness-death model
  • Claims data
  • Illness-death model
  • Scenario analysis
  • Age- and sex-specific incidence and prevalence of T1D in 2010 estimated from claims data, then projected to 2040 with the illness-death model

Main finding

As reported in the abstract

Projected number of people with T1D in Germany

Constant 2010 prevalence applied to official population projections

252 000

+1% vs 2010

Scenarios with different annual trends of incidence and mortality

between 292 000 (+18%) and 327 000 (+32%)

Original publication

Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data. BMJ Open Diabetes Res Care. Published 6 April 2023. doi:10.1136/bmjdrc-2022-003156

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.